Herbies Headshop

Medical Cannabis News & Information

Cannabis Can Successfully Treat Epilepsy in Children, Says New Study

on . Posted in Medical Cannabis News & Information

A new study published in this month’s issue of the journal Epilepsy Behavior has found that many parents with epileptic children are turning to cannabis-based medicines to treat their seizures, and in a large majority of instances, it’s successful in doing so.

“Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays, and impaired quality of life. In these treatment-resistant epilepsies, families often seek alternative treatments”, begins the study’s abstract. “This survey explored the use of cannabidiol-enriched cannabis in children with treatment-resistant epilepsy.”

New Study: Cannabis May Protect Against, Treat Symptoms of Stroke

on . Posted in Medical Cannabis News & Information

A recent study published by the National Institute of Health and the journal Translational Stroke Research has found that activation of the body’s cannabinoid receptors can reduce the harmful effects of strokes, and can even prevent them entirely.

For the study researchers at the Department of Pathology at Temple University School of Medicine used mouse models to examine the effects of activating the body’s cannabinoid receptors on transient middle cerebral artery occlusion/reperfusion injury (MCAO/R). They found that; “In conclusion, administration of the CB2R agonist/CB1R antagonist combination causes a significant reduction in infarct size in the MCAO/R model.”

Orphan Drug Designation Granted for GW Pharmaceuticals Epidiolex in Dravet syndrome by the FDA

on . Posted in Medical Cannabis News & Information

London, UK; 15 November 2013: GW Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Epidiolex®, our product candidate that contains plant-derived Cannabidiol (CBD) as its active ingredient, for use in treating children with Dravet syndrome, a rare and severe form of infantile-onset, genetic, drug-resistant epilepsy syndrome. Epidiolex is an oral liquid formulation of a highly purified extract of CBD, a non-psychoactive molecule from the cannabis plant. Following receipt of this orphan designation, GW anticipates holding a pre-IND meeting with the FDA in the near future to discuss a development plan for Epidiolex in Dravet syndrome.

New Study Finds Cannabis May Prevent Erectile Dysfunction

on . Posted in Medical Cannabis News & Information

An interesting new study published by the journal Clinicaland Developmental Immunology and the National Institute of Health has found that activation of the body’s cannabinoid receptors – something done naturally by cannabis – can actually reduce the risk of erectile dysfunction in those with hypercholesterolemia. According to the study’s researchers, hypercholesterolemia (which is the presence of high levels of cholesterol in the blood) is “one of the most important risk factors for erectile dysfunction, mostly due to the impairment of oxidative stress and endothelial function in the penis”.